These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 15368992)

  • 1. Evaluation of blend uniformity and content uniformity based on 2003 stratified sampling guidance and 1999 blend uniformity analysis guidance: product A.
    Howard-Sparks M; Gawlikowski A;
    PDA J Pharm Sci Technol; 2004; 58(4):222-30. PubMed ID: 15368992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of stratefied sampling of blend and dosage units to demonstrate adequacy of mix for powder blends.
    Boehm G; Clark J; Dietrick J; Foust L; Garcia T; Gavini M; Gelber L; Geoffroy JM; Hoblitzell J; Jimenez P; Mergen G; Muzzio F; Planchard J; Prescott J; Timmermans J; Takiar N
    PDA J Pharm Sci Technol; 2003; 57(2):64-74. PubMed ID: 14674508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of a blend-sampling technique to assess the uniformity of a powder mixture.
    Garcia TP; Wilkinson SJ; Scott JF
    Drug Dev Ind Pharm; 2001 Apr; 27(4):297-307. PubMed ID: 11411897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Science and Risk-Based Pragmatic Methodology for Blend and Content Uniformity Assessment.
    Sayeed-Desta N; Pazhayattil AB; Collins J; Doshi C
    AAPS PharmSciTech; 2018 Apr; 19(3):1483-1492. PubMed ID: 29214608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How do formulation and process parameters impact blend and unit dose uniformity? Further analysis of the product quality research institute blend uniformity working group industry survey.
    Hancock BC; Garcia-Munoz S
    J Pharm Sci; 2013 Mar; 102(3):982-6. PubMed ID: 23280670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Content uniformity acceptance limit for a validation batch--suppositories, transdermal systems, and inhalations.
    Senderak ET
    Drug Dev Ind Pharm; 2009 Jun; 35(6):735-7. PubMed ID: 19514989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality assurance test of delivered dose uniformity of multiple-dose inhaler and dry powder inhaler drug products.
    Tsong Y; Dong X; Shen M; Lostritto RT
    J Biopharm Stat; 2015; 25(2):328-38. PubMed ID: 25357132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose Uniformity of Scored and Unscored Tablets: Application of the FDA Tablet Scoring Guidance for Industry.
    Ciavarella AB; Khan MA; Gupta A; Faustino PJ
    PDA J Pharm Sci Technol; 2016 11/12; 70(6):523-532. PubMed ID: 27974592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blend uniformity analysis of pharmaceutical products by Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS).
    Fitzpatrick D; Scanlon E; Krüse J; Vos B; Evans-Hurson R; Fitzpatrick E; McSweeney S
    Int J Pharm; 2012 Nov; 438(1-2):134-9. PubMed ID: 22884840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrete element method (DEM) simulations of stratified sampling during solid dosage form manufacturing.
    Hancock BC; Ketterhagen WR
    Int J Pharm; 2011 Oct; 418(2):265-72. PubMed ID: 21635943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of statistical analysis of blend and dosage unit content uniformity data obtained from the Product Quality Research Institute Blend Uniformity Working Group data-mining effort.
    Boehm G; Clark J; Dietrick J; Foust L; Garcia T; Gavini M; Geoffroy JM; Jimenez P; Mergen G; Muzzio F; Planchard J; Prescott J; Timmermans J; Takiar N; Whiteman D;
    PDA J Pharm Sci Technol; 2004; 58(2):62-74. PubMed ID: 15113072
    [No Abstract]   [Full Text] [Related]  

  • 12. Probability of passing dissolution acceptance criteria for an immediate release tablet.
    Dumont ML; Berry MR; Nickerson B
    J Pharm Biomed Anal; 2007 May; 44(1):79-84. PubMed ID: 17379465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The study of the applicability of content uniformity and weight variation test--the state of commercial tablets and capsules in Japan.
    Katori N; Aoyagi N; Kojima S
    Chem Pharm Bull (Tokyo); 2001 Nov; 49(11):1412-9. PubMed ID: 11724231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the performance of two sample thieves for the determination of the content uniformity of a powder blend.
    Garcia TP; Taylor MK; Pande GS
    Pharm Dev Technol; 1998 Feb; 3(1):7-12. PubMed ID: 9532595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blend uniformity analysis: validation and in-process testing. Technical Report No. 25. PDA (Parenteral Drug association).
    Berman J; Elinski DE; Gonzales CR; Hofer JD; Jimenez PJ; Planchard JA; Tlachac RJ; Vogel PF
    PDA J Pharm Sci Technol; 1997; 51 Suppl 3():i-iii, S1-99. PubMed ID: 9448437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Content uniformity and assay requirements in current regulations.
    Bánfai B; Ganzler K; Kemény S
    J Chromatogr A; 2007 Jul; 1156(1-2):206-12. PubMed ID: 17109871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of process parameters on content uniformity of a low dose active pharmaceutical ingredient in a tablet formulation according to GMP.
    Muselík J; Franc A; Doležel P; Goněc R; Krondlová A; Lukášová I
    Acta Pharm; 2014 Sep; 64(3):355-67. PubMed ID: 25296681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adequacy and verifiability of pharmaceutical mixtures and dose units by variographic analysis (Theory of Sampling) - A call for a regulatory paradigm shift.
    Esbensen KH; Román-Ospino AD; Sanchez A; Romañach RJ
    Int J Pharm; 2016 Feb; 499(1-2):156-174. PubMed ID: 26707245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing for uniformity: sampling plans in pharmacopeias for weight, volume, and content uniformity.
    Pietra V; Setnikar I
    J Pharm Sci; 1970 Apr; 59(4):530-5. PubMed ID: 5440682
    [No Abstract]   [Full Text] [Related]  

  • 20. Sanofi Pharmaceuticals, Inc., et al.; withdrawal of approval of 21 new drug applications and 62 abbreviated new drug applications--FDA. Notice.
    Fed Regist; 1998 May; 63(91):26191-3. PubMed ID: 10179336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.